CN1099640A - External compress medicine for curing osteitis ossificans - Google Patents
External compress medicine for curing osteitis ossificans Download PDFInfo
- Publication number
- CN1099640A CN1099640A CN 94100274 CN94100274A CN1099640A CN 1099640 A CN1099640 A CN 1099640A CN 94100274 CN94100274 CN 94100274 CN 94100274 A CN94100274 A CN 94100274A CN 1099640 A CN1099640 A CN 1099640A
- Authority
- CN
- China
- Prior art keywords
- rhizoma
- medicine
- radix
- hyperosteogeny
- realgar
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 24
- 206010031149 Osteitis Diseases 0.000 title description 2
- 208000018339 bone inflammation disease Diseases 0.000 title description 2
- 229910052957 realgar Inorganic materials 0.000 claims abstract description 6
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims abstract description 5
- 206010005963 Bone formation increased Diseases 0.000 claims description 17
- 241000903946 Clematidis Species 0.000 claims description 9
- 241000283956 Manis Species 0.000 claims description 7
- 241001163443 Daphne giraldii Species 0.000 claims description 6
- 210000000582 semen Anatomy 0.000 claims description 6
- RSWGJHLUYNHPMX-ONCXSQPRSA-N abietic acid Chemical compound C([C@@H]12)CC(C(C)C)=CC1=CC[C@@H]1[C@]2(C)CCC[C@@]1(C)C(O)=O RSWGJHLUYNHPMX-ONCXSQPRSA-N 0.000 claims description 5
- WABPQHHGFIMREM-UHFFFAOYSA-N lead(0) Chemical compound [Pb] WABPQHHGFIMREM-UHFFFAOYSA-N 0.000 claims description 5
- 239000000470 constituent Substances 0.000 claims 1
- 239000008280 blood Substances 0.000 abstract description 9
- 210000004369 blood Anatomy 0.000 abstract description 6
- 230000017531 blood circulation Effects 0.000 abstract description 5
- 210000003734 kidney Anatomy 0.000 abstract description 4
- 206010061218 Inflammation Diseases 0.000 abstract description 3
- 208000002193 Pain Diseases 0.000 abstract description 3
- 230000004054 inflammatory process Effects 0.000 abstract description 3
- 210000004185 liver Anatomy 0.000 abstract description 2
- 230000001737 promoting effect Effects 0.000 abstract description 2
- 239000004615 ingredient Substances 0.000 abstract 2
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 abstract 1
- MUKYLHIZBOASDM-UHFFFAOYSA-N 2-[carbamimidoyl(methyl)amino]acetic acid 2,3,4,5,6-pentahydroxyhexanoic acid Chemical compound NC(=N)N(C)CC(O)=O.OCC(O)C(O)C(O)C(O)C(O)=O MUKYLHIZBOASDM-UHFFFAOYSA-N 0.000 abstract 1
- RSWGJHLUYNHPMX-UHFFFAOYSA-N Abietic-Saeure Natural products C12CCC(C(C)C)=CC2=CCC2C1(C)CCCC2(C)C(O)=O RSWGJHLUYNHPMX-UHFFFAOYSA-N 0.000 abstract 1
- 241000173529 Aconitum napellus Species 0.000 abstract 1
- 241000601164 Clematis orientalis Species 0.000 abstract 1
- 244000163122 Curcuma domestica Species 0.000 abstract 1
- 235000003392 Curcuma domestica Nutrition 0.000 abstract 1
- 244000111489 Gardenia augusta Species 0.000 abstract 1
- 235000018958 Gardenia augusta Nutrition 0.000 abstract 1
- 244000018716 Impatiens biflora Species 0.000 abstract 1
- 235000015912 Impatiens biflora Nutrition 0.000 abstract 1
- 241000283966 Pholidota <mammal> Species 0.000 abstract 1
- 235000008081 Rheum officinale Nutrition 0.000 abstract 1
- 240000001745 Rheum palmatum Species 0.000 abstract 1
- KHPCPRHQVVSZAH-HUOMCSJISA-N Rosin Natural products O(C/C=C/c1ccccc1)[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 KHPCPRHQVVSZAH-HUOMCSJISA-N 0.000 abstract 1
- 235000005155 Tanacetum balsamita Nutrition 0.000 abstract 1
- 241000819233 Tribulus <sea snail> Species 0.000 abstract 1
- 229940023019 aconite Drugs 0.000 abstract 1
- 230000003213 activating effect Effects 0.000 abstract 1
- 229940116229 borneol Drugs 0.000 abstract 1
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 abstract 1
- 235000003373 curcuma longa Nutrition 0.000 abstract 1
- 230000003467 diminishing effect Effects 0.000 abstract 1
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- KHPCPRHQVVSZAH-UHFFFAOYSA-N trans-cinnamyl beta-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OCC=CC1=CC=CC=C1 KHPCPRHQVVSZAH-UHFFFAOYSA-N 0.000 abstract 1
- 229940047183 tribulus Drugs 0.000 abstract 1
- 235000013976 turmeric Nutrition 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 15
- 229940079593 drug Drugs 0.000 description 6
- 208000024891 symptom Diseases 0.000 description 6
- 238000010521 absorption reaction Methods 0.000 description 4
- 230000000857 drug effect Effects 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 230000000149 penetrating effect Effects 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 206010020880 Hypertrophy Diseases 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000003750 conditioning effect Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000008030 elimination Effects 0.000 description 2
- 238000003379 elimination reaction Methods 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 238000013508 migration Methods 0.000 description 2
- 230000005012 migration Effects 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 108010048734 sclerotin Proteins 0.000 description 2
- 208000006820 Arthralgia Diseases 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 240000001972 Gardenia jasminoides Species 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 230000007882 cirrhosis Effects 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 230000003412 degenerative effect Effects 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 238000013467 fragmentation Methods 0.000 description 1
- 238000006062 fragmentation reaction Methods 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 239000000865 liniment Substances 0.000 description 1
- 229940040145 liniment Drugs 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 235000019633 pungent taste Nutrition 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The ingredients of the recipe of the invented medicine are divided into two groups, the first serves the actions of expelling wind and removing dampness, clearing and activating the channels and collaterals, promoting blood circulation and removing blood stasis, tonifying the kidney and invigorating the liver, removing the stagnation of obstruction and softening hard masses, as well as diminishing inflammation and relieving pain. The ingredients of the first group consists of (by weight percentages) rhizome of chuanxiong 8-15%, cape jasmine 8-12%, turmeric 8-12%, raw wild aconite root 3-8%, rosin 1-5%, borneol 1-5%, root of Chinese clematis 5-12%, pangolin scales 1-8%, red lead 1-3%, white tribulus fruit 5-10%, realgar 1-3%, rhizoma Arisae matis 1-5%, seed of garden balsam 1-8% and Chinese rhubarb 2-8%; the second group features strong pemiability and is capable of increasing the absorbing ability of medicine, which consists of white mastard seed 20-40% and bark of Daphne 8-15%. said .
Description
The present invention relates to a kind of Chinese herbal medicine, especially relate to a kind of application compress for the treatment of hyperosteogeny.
The method of existing treatment hyperosteogeny is generally three kinds: oral medicine, medicine for external use and affect massage.The oral medicine processor is more, make complicated, and cost height, in the course of processing, most of active ingredient is destroyed to be fallen, and takes the back poor effect, and side effect is arranged.But though affect the respite patient's that massages pain, can not effect a permanent cure, also unfavorable sometimes to the hyperosteogeny position, can cause fragmentation of pathological changes sclerotin and local inflammation.Publication number is the treatment liquid that 1049453 Chinese patent literature discloses a kind of hyperosteogeny, for aqueous liniment, though can exempt the side effect of oral medicine, but it is volatile, unsatisfactory curative effect, the open announcement is the unguentum and the powder of 1045525 and 1051675 the disclosed treatment hyperosteogeny of Chinese patent literature, and the treatment hyperosteogeny is had certain effect, but drug effect is mutually promoted between its component, and absorption of human body drug effect and comprehensive elimination are not good enough because of the effect of the various symptoms that hyperosteogeny causes.
The object of the present invention is to provide a kind of drug penetration strong, drug effect is mutually promoted, and is evident in efficacy, the various symptoms that can comprehensive elimination cause because of hyperosteogeny, the application compress for the treatment of both the principal and the secondary aspects of a disease at the same time and treatment hyperosteogeny without any side effects.
For realizing purpose of the present invention, the present invention has taked following technical scheme: be mostly to cause that by the empty institute that loses of stagnation of QI-blood and kidney this fact, the present invention be furnished with Radix Aconiti Kusnezoffii, Squama Manis and the Radix Clematidis of can expelling wind and removing dampness invigorating blood circulation at hyperosteogeny; Rhizoma Chuanxiong, Squama Manis, Radix Clematidis, Fructus Atriplicis Sibiricae and the Fructus Gardeniae of energy vessel conditioning QI and blood regulating; Energy restorative Semen Impatientis of softening the hard mass and Radix Clematidis; Energy removing mass piece is except that Realgar, Colophonium, Plumbum preparatium, Borneolum Syntheticum, Rhizoma Curcumae Longae, the Radix Et Rhizoma Rhei of arthralgia chiefly caused by damp pathogen, clearing away damp-heat and anti-inflammatory analgetic; In order to strengthen the absorption of human body to medicine, the present invention also adds very strong penetrating power, can guide Semen Sinapis Albae and Daphne giraldii Nitsche that all medicines enter the affected part, it is characterized in that the percentage by weight of above-mentioned each component is:
Semen Sinapis Albae 20-40% Daphne giraldii Nitsche 8-15% Rhizoma Chuanxiong 8-15% Fructus Gardeniae 8-12%
Rhizoma Curcumae Longae 8-12% Radix Aconiti Kusnezoffii 3-% Colophonium 1-5% Borneolum Syntheticum 1-5%
Radix Clematidis 5-12% Squama Manis 1-8% Plumbum preparatium 1-3% Fructus Atriplicis Sibiricae 5-10%
Realgar 1-3% Rhizoma Arisaematis 1-5% Semen Impatientis 1-8% Radix Et Rhizoma Rhei 2-8%
The present invention has following advantage and effect
1, treating both the principal and the secondary aspects of a disease at the same time can be eliminated in all directions by the caused various symptoms of hyperosteogeny.Hyperosteogeny is many to be caused by two kinds of reasons, the one, the stagnation of QI-blood type, the one, the empty type that loses of kidney, first type symptom mostly is stagnation of QI-blood, grain is obstructed, second type symptom mostly is wind and cold and corrodes, damp and hot phlegm stagnating in meridian joint, thereby cause the degenerative cirrhosis of human body cartilage position, hypertrophy, the present invention both had been furnished with dredge the meridian passage, the prescription of blood circulation promoting and blood stasis dispelling is furnished with the strong liver of energy the kidney invigorating again, the composition of clearing away damp-heat also adds simultaneously and can soften the hypertrophy sclerotin, the medicine of removing mass piece and anti-inflammatory analgetic, both eliminated the root that causes hyperosteogeny, eliminated again by the caused hyperosteogeny of these reasons, inflammation, symptoms such as pain.
2, drug effect is interweaved, mutually promotes between each composition of the present invention.The function that Squama Manis among the present invention, the existing expelling wind and removing dampness of Radix Clematidis are invigorated blood circulation has the effect of vessel conditioning QI and blood regulating again, and Radix Clematidis also has the effect of blood stasis dispelling, softening the hard mass, removing mass piece simultaneously; The restorative effect of the existing softening the hard mass of Semen Impatientis among the present invention has again that blood stasis dispelling is invigorated blood circulation, the effect of removing mass piece, and function is interweaved and promotes between each composition, makes the present invention become an organic whole.
3, this prescription penetrating power is strong, and medicine is easy to absorption of human body, and is evident in efficacy.It is extremely strong to contain penetrating power among the present invention, can expand pore again, and the guiding other medicines enter the Semen Sinapis Albae and the Daphne giraldii Nitsche in affected part, and this can strengthen the absorption of human body to medicine, improves the curative effect of medicine, and the present invention uses through 120 patients, and effective percentage reaches 94%.
4, strong drug action of the present invention, healing time is short.Externally used medicine bag manufactured according to the present invention, after place application, but also its place's use of migration.
The present invention is further detailed explanation below in conjunction with specific embodiment.
It below is a kind of specific embodiments that can treat the application compress of hyperosteogeny of one-tenth produced according to the present invention.
At first select raw material for use according to following weight:
Semen Sinapis Albae 25 gram Daphne giraldii Nitsche 10 gram Rhizoma Chuanxiongs 10 gram Fructus Gardeniaes 10 grams
Rhizoma Curcumae Longae 10 gram Radix Aconiti Kusnezoffii 4 gram Colophonium 2 gram Borneolum Syntheticums 2 grams
Radix Clematidis 6 gram Squama Maniss 4 gram Plumbum preparatiums 2 gram Fructus Atriplicis Sibiricaees, 5 grams
Realgar 1 gram Rhizoma Arisaematis 1 gram Semen Impatientis 4 gram Radix Et Rhizoma Rhei 4 grams
Then according to following prepared:
1, said medicine is dried or dried, grind into powder is crossed 200 mesh sieves, mix homogeneously separately.
2, be made into round or square packaging bag with plumety, diameter or length are about 9 centimetres, and the medicated powder about 20 grams of packing in every bag promptly is prepared into a kind of application compress that can treat hyperosteogeny.
During use medicated bag put in the warm water and soak into, pinch unnecessary moisture content (pinching does not drip is advisable), till again medicated bag being rubbed when the medicine color all is penetrated into cloth cover, medicated bag can be fixed on the affected part uses, the drug of topical application time begins when treating local spinosity hotness to calculate, general spring and autumn, the sky was no more than 45 minutes, was no more than 40 minutes summer, was no more than 50 minutes winter.
The efficacy of a drug of the present invention is strong, and this externally used medicine bag is as place application, but the time arrive after also its place of migration use, also can the application simultaneously of several places, healing time is short, the curative effect height.
Claims (1)
- A kind of application compress that are used for the treatment of hyperosteogeny, it is characterized in that: the constituent of this medicine comprises Semen Sinapis Albae, Daphne giraldii Nitsche, Rhizoma Chuanxiong, Fructus Gardeniae, Rhizoma Curcumae Longae, Radix Aconiti Kusnezoffii, Colophonium, Borneolum Syntheticum, Radix Clematidis, Squama Manis, Plumbum preparatium, Fructus Atriplicis Sibiricae, Realgar, Rhizoma Arisaematis, Semen Impatientis, Radix Et Rhizoma Rhei, and wherein the percentage by weight of each component is:Semen Sinapis Albae 20-40% Daphne giraldii Nitsche 8-15% Rhizoma Chuanxiong 8-15% Fructus Gardeniae 8-15%Rhizoma Curcumae Longae 8-12% Radix Aconiti Kusnezoffii 3-8% Colophonium 1-5% Borneolum Syntheticum 1-5%Radix Clematidis 5-12% Squama Manis 1-8% Plumbum preparatium 1-3% Fructus Atriplicis Sibiricae 5-10%Realgar 1-3% Rhizoma Arisaematis 1-5% Semen Impatientis 1-8% Radix Et Rhizoma Rhei 2-8%
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 94100274 CN1099640A (en) | 1994-01-14 | 1994-01-14 | External compress medicine for curing osteitis ossificans |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 94100274 CN1099640A (en) | 1994-01-14 | 1994-01-14 | External compress medicine for curing osteitis ossificans |
Publications (1)
Publication Number | Publication Date |
---|---|
CN1099640A true CN1099640A (en) | 1995-03-08 |
Family
ID=5029538
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 94100274 Pending CN1099640A (en) | 1994-01-14 | 1994-01-14 | External compress medicine for curing osteitis ossificans |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1099640A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1059593C (en) * | 1998-11-17 | 2000-12-20 | 高宏大 | Ointment for eliminating pain of spur and preparation process thereof |
CN1329076C (en) * | 2005-11-11 | 2007-08-01 | 齐殿忠 | Plaster for orthopaedics and its preparation method |
CN104127830A (en) * | 2014-08-21 | 2014-11-05 | 天津泰源中草药技术开发有限公司 | Traditional Chinese medicine for treating hyperosteogeny |
-
1994
- 1994-01-14 CN CN 94100274 patent/CN1099640A/en active Pending
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1059593C (en) * | 1998-11-17 | 2000-12-20 | 高宏大 | Ointment for eliminating pain of spur and preparation process thereof |
CN1329076C (en) * | 2005-11-11 | 2007-08-01 | 齐殿忠 | Plaster for orthopaedics and its preparation method |
CN104127830A (en) * | 2014-08-21 | 2014-11-05 | 天津泰源中草药技术开发有限公司 | Traditional Chinese medicine for treating hyperosteogeny |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1236793C (en) | Medicinal formula for curing sciatic nerve disease and protrusion of lumbar intervertebral disc | |
CN102579929A (en) | Ointment for arthralgia-syndrome and its preparation method | |
CN1099640A (en) | External compress medicine for curing osteitis ossificans | |
CN107007714A (en) | It is a kind of that there is the exterior-applied medical wine for promoting poroma nucleus formation | |
CN1260984A (en) | Exterior-applied Chinese medicine for treating trauma | |
CN101496875B (en) | External-use medical ointment for bone fracture | |
CN110038109A (en) | A kind of rheumatism ostealgia medicated wine | |
CN114404504A (en) | Cold-dispelling traditional Chinese medicine formula for rheumatic low back pain and preparation method thereof | |
CN1063650C (en) | Chinese medicinal pill for curing rheumatism and rheumatoid disease and its preparation method | |
WO2017220045A1 (en) | Formulation treating sprains and contusions | |
CN113082151A (en) | External Chinese herbal medicine composition for bone fracture, preparation and preparation method and application thereof | |
CN107184673A (en) | One kind treats knee osteoarthritis hot compress liquid | |
CN1069046C (en) | Liniment for treating bony spur | |
CN1181861C (en) | Spray agent for treating tendon and bone injury | |
CN1206597A (en) | Xiaojieling and preparation process thereof | |
CN1554417A (en) | Frostbite liquid | |
CN1242760C (en) | Powder preparation for treating burn and skin trauma | |
CN100350888C (en) | Thermotherapy bag for treating galactophore hyperplasia | |
CN1269499C (en) | Medicine efficacious for burn and preparation method | |
CN108888736B (en) | External-use bone reunion medicine and preparation method thereof | |
CN101062186A (en) | External medicine - Huolong liquid for diminishing inflammation and pain | |
CN1973880A (en) | Externally applied medicine for treating gouty arthritis and its prepn | |
CN110870911A (en) | Chinese herbal medicine external plaster for osmotic therapy and preparation method and application thereof | |
CN111035689A (en) | Formula for treating systemic degenerative arthritis pain and preparation method thereof | |
CN113786456A (en) | Burn and scald ointment and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C01 | Deemed withdrawal of patent application (patent law 1993) | ||
WD01 | Invention patent application deemed withdrawn after publication |